Patrick M Sweeney & Associates Inc. Invests $762,000 in The Procter & Gamble Company (NYSE:PG)

Patrick M Sweeney & Associates Inc. purchased a new stake in The Procter & Gamble Company (NYSE:PGFree Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 5,201 shares of the company’s stock, valued at approximately $762,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Wyrmwood Management LLC acquired a new stake in shares of Procter & Gamble during the 4th quarter valued at $29,000. Naples Money Management LLC bought a new position in shares of Procter & Gamble during the 4th quarter worth approximately $29,000. Criterion Capital Advisors LLC acquired a new stake in Procter & Gamble in the fourth quarter worth $33,000. MeadowBrook Investment Advisors LLC bought a new stake in Procter & Gamble in the 4th quarter valued at about $33,000. Finally, Mendota Financial Group LLC raised its position in shares of Procter & Gamble by 636.6% during the fourth quarter. Mendota Financial Group LLC now owns 302 shares of the company’s stock worth $44,000 after purchasing an additional 261 shares during the period. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Down 0.4 %

Shares of NYSE:PG traded down $0.69 on Wednesday, hitting $165.07. 4,543,152 shares of the company traded hands, compared to its average volume of 6,870,423. The company has a market cap of $389.59 billion, a PE ratio of 27.06, a PEG ratio of 3.34 and a beta of 0.43. The stock has a 50 day simple moving average of $160.23 and a 200-day simple moving average of $154.49. The Procter & Gamble Company has a 52 week low of $141.45 and a 52 week high of $166.37. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings data on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.42 by $0.10. The firm had revenue of $20.20 billion during the quarter, compared to the consensus estimate of $20.43 billion. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The company’s revenue for the quarter was up .6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.37 EPS. As a group, research analysts expect that The Procter & Gamble Company will post 6.55 earnings per share for the current year.

Procter & Gamble Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be paid a dividend of $1.0065 per share. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.44%. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.69%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. Barclays increased their price objective on Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 23rd. Argus raised their price objective on shares of Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a report on Thursday, April 25th. StockNews.com cut Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Truist Financial raised Procter & Gamble from a “hold” rating to a “buy” rating and raised their price target for the company from $160.00 to $175.00 in a report on Monday, March 11th. Finally, Stifel Nicolaus raised their price target on Procter & Gamble from $155.00 to $157.00 and gave the company a “hold” rating in a research report on Wednesday, January 24th. Seven analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $169.76.

Check Out Our Latest Report on PG

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CEO Gary A. Coombe sold 22,000 shares of the firm’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the sale, the chief executive officer now directly owns 36,845 shares of the company’s stock, valued at $5,943,835.40. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, CEO Gary A. Coombe sold 22,000 shares of Procter & Gamble stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the sale, the chief executive officer now owns 36,845 shares in the company, valued at $5,943,835.40. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CEO R. Alexandra Keith sold 776 shares of the company’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $158.11, for a total transaction of $122,693.36. Following the transaction, the chief executive officer now owns 4,859 shares of the company’s stock, valued at approximately $768,256.49. The disclosure for this sale can be found here. Insiders have sold 140,112 shares of company stock valued at $22,841,321 over the last 90 days. 0.17% of the stock is currently owned by corporate insiders.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.